13F HOLDINGS REPORT
Lion Point Capital, LP
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001013594-24-000964
Total Value
$44.9M
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ISHARES TR | 464287655 | 82,500 | $18.2M | 40.58% |
| 2 | INSMED INC | INSM | 52,200 | $3.8M | 8.49% |
| 3 | GERON CORP | GERN | 630,000 | $2.9M | 6.37% |
| 4 | ARDELYX INC | ARDX | 370,000 | $2.5M | 5.68% |
| 5 | MILESTONE PHARMACEUTICALS IN | MIST | 1,654,154 | $2.5M | 5.60% |
| 6 | BIOHAVEN LTD | BHVN | 35,400 | $1.8M | 3.94% |
| 7 | MIRUM PHARMACEUTICALS INC | MIRM | 45,000 | $1.8M | 3.91% |
| 8 | KINIKSA PHARMACEUTICALS LTD | G52694109 | 61,400 | $1.5M | 3.42% |
| 9 | BRIDGEBIO PHARMA INC | BBIO | 49,000 | $1.2M | 2.78% |
| 10 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 693,778 | $1.2M | 2.72% |
| 11 | FENNEC PHARMACEUTICALS INC | FENC | 215,000 | $1.1M | 2.39% |
| 12 | MINERALYS THERAPEUTICS INC | MLYS | 79,000 | $956,690 | 2.13% |
| 13 | SYNDAX PHARMACEUTICALS INC | SNDX | 46,200 | $889,350 | 1.98% |
| 14 | AVADEL PHARMACEUTICALS PLC | G29687103 | 64,000 | $839,360 | 1.87% |
| 15 | BLUEBIRD BIO INC | 09609G100 | 1,578,256 | $819,904 | 1.83% |
| 16 | REGENXBIO INC | RGNX | 57,750 | $605,798 | 1.35% |
| 17 | JASPER THERAPEUTICS INC | JSPRW | 32,000 | $601,920 | 1.34% |
| 18 | DISC MEDICINE INC | IRON | 7,700 | $378,378 | 0.84% |
| 19 | BENITEC BIOPHARMA INC | BNTC | 39,000 | $358,410 | 0.80% |
| 20 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 35,100 | $326,430 | 0.73% |
| 21 | SERES THERAPEUTICS INC | MCRB | 340,761 | $322,394 | 0.72% |
| 22 | LUMOS PHARMA INC | 55028X109 | 39,589 | $153,209 | 0.34% |
| 23 | MICROSOFT CORP | MSFT | 100 | $43,030 | 0.10% |
| 24 | SPRUCE BIOSCIENCES INC | SPRB | 75,000 | $35,618 | 0.08% |
| 25 | ALPHABET INC | GOOG | 100 | $16,719 | 0.04% |